Drug
ABX-1431
ABX-1431 is a pharmaceutical drug with 5 clinical trials. Historical success rate of 80.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
80.0%
Based on 4 completed trials
Completion Rate
80%(4/5)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(20%)
Phase Distribution
Ph phase_1
4
80%
Ph phase_2
1
20%
Phase Distribution
4
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
4(80.0%)
Phase 2Efficacy & side effects
1(20.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
80.0%
4 of 5 finished
Non-Completion Rate
20.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(4)
Terminated(1)
Detailed Status
Completed4
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
80.0%
Most Advanced
Phase 2
Trials by Phase
Phase 14 (80.0%)
Phase 21 (20.0%)
Trials by Status
completed480%
terminated120%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_2
Study of ABX-1431 in Adult Patients With Tourette Syndrome or Chronic Motor Tic Disorder
NCT03625453
completedphase_1
Titration Study of ABX-1431
NCT03447756
completedphase_1
An fMRI Study in Healthy Volunteers to Investigate the Effects of ABX-1431 on Experimental Hyperalgesia and Its Neural Correlates
NCT02929264
completedphase_1
A Study to Evaluate the Effects of ABX-1431 on Patients With Tourette Syndrome
NCT03058562
terminatedphase_1
A Study to Evaluate the Effects of ABX-1431 on Patients With Functional Dyspepsia
NCT02875678
Clinical Trials (5)
Showing 5 of 5 trials
NCT03625453Phase 2
Study of ABX-1431 in Adult Patients With Tourette Syndrome or Chronic Motor Tic Disorder
NCT03447756Phase 1
Titration Study of ABX-1431
NCT02929264Phase 1
An fMRI Study in Healthy Volunteers to Investigate the Effects of ABX-1431 on Experimental Hyperalgesia and Its Neural Correlates
NCT03058562Phase 1
A Study to Evaluate the Effects of ABX-1431 on Patients With Tourette Syndrome
NCT02875678Phase 1
A Study to Evaluate the Effects of ABX-1431 on Patients With Functional Dyspepsia
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5